<DOC>
	<DOCNO>NCT02326818</DOCNO>
	<brief_summary>Background : - It hard people arm spasticity focal hand dystonia control arm hand muscle . They often treat botulinum toxin ( BoNT ) injection . Electromyography electrical stimulation ( e-stim ) ultrasound use find muscles BoNT injection . Researchers want learn method faster comfortable . Objective : - To compare 2 way find muscle BoNT injection treatment focal hand dystonia upper limb spasticity . Eligibility : - Adults 18 old focal hand dystonia arm spasticity get onabotulinumtoxin-A injection protocol 85-N-0195 . Design : - Participants screen medical history physical exam . - Participants push pull device measure arm strength . They neurologic exam . Women pregnancy test . - Participants BoNT injection use either e-stim ultrasound . - For e-stim , sticky pad place arm . A needle placed muscle . A small electric shock give needle . Then injection give . - For ultrasound , probe move across skin . A screen show image muscle . Then injection give . - Participants second injection 3 month later . They method use first injection . - After session , participant rate experience . - Participants follow-up visit 1 month injection . They examine ask response treatment . Arm strength measure .</brief_summary>
	<brief_title>Comparison Electrophysiologic Ultrasound Guidance Onabotulinum Toxin A Injections Focal Upper Extremity Dystonia Spasticity</brief_title>
	<detailed_description>This study investigate use two target technique botulinum toxin ( BoNT ) injection treatment focal hand dystonia upper limb spasticity : Electrophysiologic guidance , use electrical stimulation , ultrasound . Subjects select clinical program Icahn School Medicine Mount Sinai National Institutes Health already receive upper limb onabotulinumtoxin A injection clinically . The study consist four visit . Visit one consist screen subject consent randomized one two treatment technique onaBoNT injection : 1 ) Electrophysiologic guidance use electrical stimulation 2 ) ultrasound . Visit 2 occur week 4 subject return follow visit blind evaluator measurement efficacy strength capture safety data . Visit 3 week 12 subject cross opposite treatment technique onaBoNT injection . Visit 4 occur week 16 final assessment subject measurement efficacy strength capture safety data blind evaluator .</detailed_description>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>INCLUSION CRITERIA : Confirmed diagnosis focal hand dystonia ( FHD ) upper limb spasticity Stable onabotulinumtoxinA regimen response least 2 treatment session , define 15 % difference response visual analogue scale , identical muscle target dose session . Receiving botulinum toxin injection 85N0195 Age 18 EXCLUSION CRITERIA : Contraindications botulinum toxin concomitant neuromuscular disorder neuromuscular junction disorder Pregnancy nursing Cognitive impairment and/or capacity impairment prevent reliable outcome measure selfreport .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>February 8, 2017</verification_date>
	<keyword>Dystonia</keyword>
	<keyword>Botulinum Toxin</keyword>
	<keyword>Musician 's Dystonia</keyword>
	<keyword>Spasticity</keyword>
</DOC>